(Q43651118)

English

Combination therapy with metformin plus sulphonylureas versus metformin plus DPP-4 inhibitors: association with major adverse cardiovascular events and all-cause mortality.

scientific article published on 22 May 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762119%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Combination therapy with metformin plus sulphonylureas versus metformin plus DPP-4 inhibitors: association with major adverse cardiovascular events and all-cause mortality (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762119%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

1 reference

based on heuristic

inferred from title

circulatory system

1 reference

based on heuristic

inferred from title

Sara Jenkins-Jones

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762119%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

author name string

C Ll Morgan

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762119%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

J Mukherjee

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762119%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

S E Holden

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762119%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

C J Currie

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762119%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

publication date

22 May 2014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762119%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762119%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762119%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762119%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

977-983

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762119%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12306

21 January 2018

Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12306

21 January 2018

Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12306

21 January 2018

Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12306

21 January 2018

Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12306

21 January 2018

Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12306

21 January 2018

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12306

21 January 2018

Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12306

21 January 2018

Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12306

21 January 2018

Cardiovascular safety of sulfonylureas: a meta-analysis of randomized clinical trials.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12306

21 January 2018

Treatment persistence, hypoglycaemia and clinical outcomes in type 2 diabetes patients with dipeptidyl peptidase-4 inhibitors and sulphonylureas: a primary care database analysis

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12306

21 January 2018

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12306

21 January 2018

Sulphonylurea action revisited: the post-cloning era.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12306

21 January 2018

Is impairment of ischaemic preconditioning by sulfonylurea drugs clinically important?

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12306

21 January 2018

Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12306

21 January 2018

Mortality among veterans with type 2 diabetes initiating metformin, sulfonylurea or rosiglitazone monotherapy

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12306

21 January 2018

Impact of hypoglycemia associated with antihyperglycemic medications on vascular risks in veterans with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12306

21 January 2018

Severe hypoglycemia and risks of vascular events and death

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12306

21 January 2018

Effects of intensive glucose lowering in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12306

21 January 2018

Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12306

21 January 2018

Obesity and disease management: effects of weight loss on comorbid conditions

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12306

21 January 2018

Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12306

21 January 2018

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12306

21 January 2018

The proliferating role of insulin and insulin-like growth factors in cancer

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12306

21 January 2018

Excess exposure to insulin is the primary cause of insulin resistance and its associated atherosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12306

21 January 2018

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12306

21 January 2018

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12306

21 January 2018

DPP-4 inhibitors and lipids: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12306

21 January 2018

Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12306

21 January 2018

Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12306

21 January 2018

Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12306

21 January 2018

Metformin: An Update

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12306

21 January 2018

Socioeconomic position and health among persons with diabetes mellitus: a conceptual framework and review of the literature

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12306

21 January 2018

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12306

21 January 2018

Identifiers

10.1111/DOM.12306

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762119%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24762119%20AND%20SRC:MED&resulttype=core&format=json

15 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43651118&oldid=2102325632"